- Home
- SRPT vs CCU Comparison
SRPT vs CCU Comparison
Compare SRPT & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | CCU |
|---|---|---|
| Founded | 1980 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2000 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SRPT | CCU |
|---|---|---|
| Price | $15.89 | $11.05 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 29 | 2 |
| Target Price | ★ $25.85 | $12.00 |
| AVG Volume (30 Days) | ★ 2.8M | 158.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ $5.78 | $18.35 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $10.71 |
| 52 Week High | $43.92 | $15.36 |
Technical Indicators
Market Signals| Indicator | SRPT | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 33.56 | 39.18 |
| Support Level | $15.70 | $10.81 |
| Resistance Level | $19.62 | $12.37 |
| Average True Range (ATR) | 0.73 | 0.38 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 1.96 | 6.94 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.